{ "d" : { "results": [ { "__metadata": { "uri": "http://dbpedia.org/resource/Apolizumab" }, "http://xmlns.com/foaf/0.1/isPrimaryTopicOf": { "__deferred": { "uri": "http://en.wikipedia.org/wiki/Apolizumab" } }, "http://dbpedia.org/ontology/wikiPageWikiLink": { "__deferred": { "uri": "http://dbpedia.org/resource/Category:Abandoned_drugs" } }, "http://www.w3.org/2002/07/owl#sameAs": { "__deferred": { "uri": "http://www.wikidata.org/entity/Q4780240" } }, "http://www.w3.org/1999/02/22-rdf-syntax-ns#type": { "__deferred": { "uri": "http://dbpedia.org/class/yago/Abstraction100002137" } }, "http://dbpedia.org/property/wikiPageUsesTemplate": { "__deferred": { "uri": "http://dbpedia.org/resource/Template:Cascite" } }, "http://www.w3.org/1999/02/22-rdf-syntax-ns#type": { "__deferred": { "uri": "http://dbpedia.org/ontology/MonoclonalAntibody" } }, "http://www.w3.org/1999/02/22-rdf-syntax-ns#type": { "__deferred": { "uri": "http://www.wikidata.org/entity/Q8386" } }, "http://www.w3.org/1999/02/22-rdf-syntax-ns#type": { "__deferred": { "uri": "http://dbpedia.org/class/yago/Macromolecule114944888" } }, "http://dbpedia.org/property/wikiPageUsesTemplate": { "__deferred": { "uri": "http://dbpedia.org/resource/Template:Keggcite" } }, "http://dbpedia.org/property/verifiedrevid": "457135624", "http://www.w3.org/2000/01/rdf-schema#label": "Apolizumab", "http://dbpedia.org/ontology/wikiPageWikiLink": { "__deferred": { "uri": "http://dbpedia.org/resource/Cancer" } }, "http://www.w3.org/1999/02/22-rdf-syntax-ns#type": { "__deferred": { "uri": "http://dbpedia.org/class/yago/Matter100020827" } }, "http://dbpedia.org/property/kegg": "D02967", "http://www.w3.org/2000/01/rdf-schema#label": "أبوليزوماب", "http://dbpedia.org/property/wikiPageUsesTemplate": { "__deferred": { "uri": "http://dbpedia.org/resource/Template:Drugbox" } }, "http://purl.org/dc/terms/subject": { "__deferred": { "uri": "http://dbpedia.org/resource/Category:Monoclonal_antibodies" } }, "http://www.w3.org/1999/02/22-rdf-syntax-ns#type": { "__deferred": { "uri": "http://dbpedia.org/class/yago/Unit109465459" } }, "http://www.w3.org/1999/02/22-rdf-syntax-ns#type": { "__deferred": { "uri": "http://dbpedia.org/ontology/Drug" } }, "http://dbpedia.org/property/mabType": "mab", "http://purl.org/dc/terms/subject": { "__deferred": { "uri": "http://dbpedia.org/resource/Category:Abandoned_drugs" } }, "http://dbpedia.org/ontology/casNumber": "267227-08-7", "http://dbpedia.org/property/wikiPageUsesTemplate": { "__deferred": { "uri": "http://dbpedia.org/resource/Template:Drugbankcite" } }, "http://dbpedia.org/property/wikiPageUsesTemplate": { "__deferred": { "uri": "http://dbpedia.org/resource/Template:Short_description" } }, "http://www.w3.org/1999/02/22-rdf-syntax-ns#type": { "__deferred": { "uri": "http://dbpedia.org/class/yago/OrganicCompound114727670" } }, "http://www.w3.org/2002/07/owl#sameAs": { "__deferred": { "uri": "https://global.dbpedia.org/id/4RNeY" } }, "http://dbpedia.org/property/wikiPageUsesTemplate": { "__deferred": { "uri": "http://dbpedia.org/resource/Template:Chemspidercite" } }, "http://dbpedia.org/property/wikiPageUsesTemplate": { "__deferred": { "uri": "http://dbpedia.org/resource/Template:Monoclonal-antibody-stub" } }, "http://dbpedia.org/property/wikiPageUsesTemplate": { "__deferred": { "uri": "http://dbpedia.org/resource/Template:Fdacite" } }, "http://dbpedia.org/property/verifiedfields": "changed", "http://www.w3.org/ns/prov#wasDerivedFrom": { "__deferred": { "uri": "http://en.wikipedia.org/wiki/Apolizumab?oldid=1092521214&ns=0" } }, "http://www.w3.org/1999/02/22-rdf-syntax-ns#type": { "__deferred": { "uri": "http://www.w3.org/2002/07/owl#Thing" } }, "http://dbpedia.org/ontology/kegg": "D02967", "http://www.w3.org/1999/02/22-rdf-syntax-ns#type": { "__deferred": { "uri": "http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject" } }, "http://dbpedia.org/property/chemspiderid": "none", "http://dbpedia.org/property/wikiPageUsesTemplate": { "__deferred": { "uri": "http://dbpedia.org/resource/Template:Reflist" } }, "http://www.w3.org/1999/02/22-rdf-syntax-ns#type": { "__deferred": { "uri": "http://dbpedia.org/class/yago/Molecule114682133" } }, "http://www.w3.org/2000/01/rdf-schema#comment": "أبوليزوماب هو جسم مضاد وحيد النسيلة يدرس حالياً ليستخدم في أورام الدم.", "http://www.w3.org/1999/02/22-rdf-syntax-ns#type": { "__deferred": { "uri": "http://dbpedia.org/class/yago/Material114580897" } }, "http://www.w3.org/1999/02/22-rdf-syntax-ns#type": { "__deferred": { "uri": "http://dbpedia.org/class/yago/WikicatMonoclonalAntibodies" } }, "http://www.w3.org/2002/07/owl#sameAs": { "__deferred": { "uri": "http://rdf.freebase.com/ns/m.0277mns" } }, "http://dbpedia.org/ontology/wikiPageWikiLink": { "__deferred": { "uri": "http://dbpedia.org/resource/Aseptic_meningitis" } }, "http://dbpedia.org/ontology/wikiPageRevisionID": "1092521214", "http://www.w3.org/1999/02/22-rdf-syntax-ns#type": { "__deferred": { "uri": "http://dbpedia.org/class/yago/Antibody115027189" } }, "http://www.w3.org/2000/01/rdf-schema#comment": "Apolizumab is a humanized monoclonal antibody intended for use in hematologic cancers. Development was abandoned in 2005, because of toxic effects and lack of efficacy in humans. The observed dose limiting toxic effects were aseptic meningitis and hemolytic uremia.", "http://dbpedia.org/ontology/wikiPageWikiLink": { "__deferred": { "uri": "http://dbpedia.org/resource/Monoclonal_antibody" } }, "http://www.w3.org/1999/02/22-rdf-syntax-ns#type": { "__deferred": { "uri": "http://dbpedia.org/ontology/ChemicalSubstance" } }, "http://dbpedia.org/property/atcPrefix": "none", "http://dbpedia.org/ontology/wikiPageLength": "3153", "http://www.w3.org/1999/02/22-rdf-syntax-ns#type": { "__deferred": { "uri": "http://dbpedia.org/class/yago/Protein114728724" } }, "http://www.w3.org/1999/02/22-rdf-syntax-ns#type": { "__deferred": { "uri": "http://dbpedia.org/class/yago/PhysicalEntity100001930" } }, "http://dbpedia.org/property/unii": "G88KCP51RE", "http://purl.org/linguistics/gold/hypernym": { "__deferred": { "uri": "http://dbpedia.org/resource/Antibody" } }, "http://dbpedia.org/ontology/wikiPageID": "8552611", "http://www.w3.org/1999/02/22-rdf-syntax-ns#type": { "__deferred": { "uri": "http://umbel.org/umbel/rc/DrugProduct" } }, "http://www.w3.org/1999/02/22-rdf-syntax-ns#type": { "__deferred": { "uri": "http://dbpedia.org/class/yago/Substance100019613" } }, "http://dbpedia.org/ontology/fdaUniiCode": "G88KCP51RE", "http://dbpedia.org/property/wikiPageUsesTemplate": { "__deferred": { "uri": "http://dbpedia.org/resource/Template:Antineoplastic-drug-stub" } }, "http://www.w3.org/2002/07/owl#sameAs": { "__deferred": { "uri": "http://ar.dbpedia.org/resource/أبوليزوماب" } }, "http://www.w3.org/1999/02/22-rdf-syntax-ns#type": { "__deferred": { "uri": "http://dbpedia.org/class/yago/Chemical114806838" } }, "http://dbpedia.org/ontology/abstract": "أبوليزوماب هو جسم مضاد وحيد النسيلة يدرس حالياً ليستخدم في أورام الدم.", "http://www.w3.org/1999/02/22-rdf-syntax-ns#type": { "__deferred": { "uri": "http://dbpedia.org/class/yago/Compound114818238" } }, "http://dbpedia.org/ontology/wikiPageWikiLink": { "__deferred": { "uri": "http://dbpedia.org/resource/HLA-DR" } }, "http://www.w3.org/1999/02/22-rdf-syntax-ns#type": { "__deferred": { "uri": "http://dbpedia.org/class/yago/Part113809207" } }, "http://dbpedia.org/property/wikiPageUsesTemplate": { "__deferred": { "uri": "http://dbpedia.org/resource/Template:Monoclonals_for_immune_system" } }, "http://dbpedia.org/property/source": "zu/o", "http://www.w3.org/1999/02/22-rdf-syntax-ns#type": { "__deferred": { "uri": "http://dbpedia.org/class/yago/Thing100002452" } }, "http://www.w3.org/2002/07/owl#sameAs": { "__deferred": { "uri": "http://yago-knowledge.org/resource/Apolizumab" } }, "http://www.w3.org/1999/02/22-rdf-syntax-ns#type": { "__deferred": { "uri": "http://dbpedia.org/class/yago/Relation100031921" } }, "http://dbpedia.org/ontology/wikiPageWikiLink": { "__deferred": { "uri": "http://dbpedia.org/resource/Uremia" } }, "http://dbpedia.org/property/_target": "HLA-DR beta", "http://www.w3.org/1999/02/22-rdf-syntax-ns#type": { "__deferred": { "uri": "http://dbpedia.org/class/yago/MonoclonalAntibody115029781" } }, "http://dbpedia.org/property/casNumber": "267227", "http://dbpedia.org/property/type": "mab", "http://dbpedia.org/ontology/abstract": "Apolizumab is a humanized monoclonal antibody intended for use in hematologic cancers. Development was abandoned in 2005, because of toxic effects and lack of efficacy in humans. The observed dose limiting toxic effects were aseptic meningitis and hemolytic uremia.", "http://dbpedia.org/ontology/wikiPageWikiLink": { "__deferred": { "uri": "http://dbpedia.org/resource/Category:Monoclonal_antibodies" } } } ], "__count": "1" } }
  NODES